Salivary biomarkers as potential diagnostic tool for temporomandibular disorders: A comprehensive review

References

• Goulet JP, Velly AM, editors. Orofacial pain biomarkers. Berlin, Heidelberg: Springer Berlin Heidelberg Berlin Heidelberg; 2017. doi: 10.1007/978-3-662-53994-1
   Google Scholar
• Shrivastava M, Battaglino R, Ye L. A comprehensive review on biomarkers associated with painful temporomandibular disorders. Int J Oral Sci. 2021 Dec;13(1):23. doi: 10.1038/s41368-021-00129-1
   PubMed Web of Science ®Google Scholar
• Schiffman E, Ohrbach R, Truelove E, et al. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for clinical and research applications: recommendations of the International RDC/TMD consortium network* and orofacial pain special interest group†. J Oral Facial Pain Headache. 2014 Jan;28(1):6–27.
   PubMed Web of Science ®Google Scholar
• Schiffman E, Ohrbach R. Executive summary of the diagnostic criteria for temporomandibular disorders for clinical and research applications. J Am Dent Assoc. 2016 Jun;147(6):438–445. doi: 10.1016/j.adaj.2016.01.007
   PubMed Web of Science ®Google Scholar
• Dominica D, Naliani S, Lelyana S, et al. Biomarkers of temporomandibular disorders. sod. 2019 Jul 14;3(1):41–47. doi: 10.28932/sod.v3i1.1782
   Google Scholar
• Williamson S, Munro C, Pickler R, et al. Comparison of biomarkers in blood and saliva in healthy adults. Nurs Res Pract. 2012;2012:1–4. doi: 10.1155/2012/246178
   Google Scholar
• Dawes C, Wong DTW. Role of saliva and salivary diagnostics in the advancement of oral health. J Dent Res. 2019 Feb;98(2):133–141. doi: 10.1177/0022034518816961
   PubMed Web of Science ®Google Scholar
• Lee YH, Wong DT. Saliva: an emerging biofluid for early detection of diseases. Am J Dent. 2009 Aug;22(4):241–248.
   PubMed Web of Science ®Google Scholar
• Javaid MA, Ahmed AS, Durand R, et al. Saliva as a diagnostic tool for oral and systemic diseases. J Oral Biol Craniofac Res. 2016 Jan;6(1):67–76. doi: 10.1016/j.jobcr.2015.08.006
   Google Scholar
• Ntovas P, Loumprinis N, Maniatakos P, et al. The effects of physical exercise on saliva composition: a comprehensive review. Dent J (Basel). 2022 Jan 5;10(1):7. doi: 10.3390/dj10010007
   PubMedGoogle Scholar
• Nazish M, Sharma S. Effect of complex training on salivary cortisol level, BOMB test and balance performance in shot-put throwers: a review. Physiother Occup Therapy J. 2014 Jul 1;7(3):139.
   Google Scholar
• Jasim H, Ghafouri B, Gerdle B, et al. Altered levels of salivary and plasma pain related markers in temporomandibular disorders. J Headache Pain. 2020 Dec;21(1):105.
   PubMed Web of Science ®Google Scholar
• Park YM, Ahn YW, Jeong SH, et al. Interleukin-8 and matrix metalloprotease 9 as salivary biomarkers of pain in patients with temporomandibular disorder myalgia: a pilot study. JOMP. 2019 Dec 30;44(4):160–168. doi: 10.14476/jomp.2019.44.4.160
   Google Scholar
• Rafni E, Y Y, Darwin E, et al. The difference of matrix metalloproteinase-9 level in saliva between myofascial pain and disc displacement of temporomandibular joint disorders. Padjadjaran J Dent. 2017 Jul 31 [[cited 2022 Feb 17]];29(2). doi: 10.24198/pjd.vol29no2.13613
   Google Scholar
• Yaman D, Alpaslan C, Akca G, et al. Correlation of molecular biomarker concentrations between synovial fluid and saliva of the patients with temporomandibular disorders. Clin Oral Invest. 2020 Dec;24(12):4455–4461.
   PubMed Web of Science ®Google Scholar
• Cê P, Barreiro B, Silva R, et al. Salivary levels of interleukin-1 in temporomandibular disorders and fibromyalgia. J Oral Facial Pain Headache. 2018 Apr;32(2):130–136. doi: 10.11607/ofph.1899
   PubMed Web of Science ®Google Scholar
• Khayamzadeh M, Mirzaii-Dizgah I, Aghababainejad P, et al. Relationship between parafunctional habits and salivary biomarkers. Front Dentfid. 2019 Dec;16(6):465–472. doi: 10.18502/fid.v16i6.3446
   PubMedGoogle Scholar
• Chinthakanan S, Laosuwan K, Boonyawong P, et al. Reduced heart rate variability and increased saliva cortisol in patients with TMD. Arch Oral Biol. 2018 Jun;90:125–129. doi: 10.1016/j.archoralbio.2018.03.011
   PubMed Web of Science ®Google Scholar
• Lalue Sanches M, Sforça ML, Guimarães Lo Turco E, et al. 1H-NMR-Based salivary metabolomics from females with temporomandibular disorders – a pilot study. Clinica Chimica Acta. 2020 Nov;510:625–632.
   PubMed Web of Science ®Google Scholar
• Rodríguez de Sotillo D, Velly AM, Hadley M, et al. Evidence of oxidative stress in temporomandibular disorders: a pilot study: oXIDATIVE STRESS in TEMPOROMANDIBULAR DISORDERS. Journal Of Oral Rehabilitation. 2011 Oct;38(10):722–728. doi: 10.1111/j.1365-2842.2011.02216.x
   PubMed Web of Science ®Google Scholar
• Sobas EM, Reinoso R, Cuadrado-Asensio R, et al. Reliability of potential pain biomarkers in the saliva of healthy subjects: inter-individual differences and intersession variability. Nater UM, editor. PLoS One. 2016 Dec 1;11(12):e0166976. doi: 10.1371/journal.pone.0166976
   PubMed Web of Science ®Google Scholar
• Sorsa T, Tjäderhane L, Salo T. Matrix metalloproteinases (MMPs) in oral diseases. Oral Dis. 2004 Nov;10(6):311–318. doi: 10.1111/j.1601-0825.2004.01038.x
   PubMed Web of Science ®Google Scholar
• Murphy G, Nagase H. Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair? Nat Clin Pract Rheumatol. 2008 Mar;4(3):128–135. doi: 10.1038/ncprheum0727
   PubMedGoogle Scholar
• Mizui T, Ishimaru J, Miyamoto K, et al. Matrix metalloproteinase-2 in synovial lavage fluid of patients with disorders of the temporomandibular joint. Br J Oral Maxillofac Surg. 2001 Aug;39(4):310–314.
   PubMed Web of Science ®Google Scholar
• Puliti M, Momi S, Falcinelli E, et al. Contribution of matrix metalloproteinase 2 to joint destruction in group B Streptococcus-induced murine arthritis. Arthritis Rheum. 2012 Apr;64(4):1089–1097.
   PubMedGoogle Scholar
• Lakhan SE, Avramut M. Matrix metalloproteinases in neuropathic pain and migraine: friends, enemies, and therapeutic targets. Pain Res Treat. 2012 Aug 28;2012:e952906. doi: 10.1155/2012/952906.
   PubMedGoogle Scholar
• Kaur J, Adya R, Tan BK, et al. Identification of chemerin receptor (ChemR23) in human endothelial cells: chemerin-induced endothelial angiogenesis. Biochem Biophys Res Commun. 2010 Jan 22;391(4):1762–1768. doi: 10.1016/j.bbrc.2009.12.150
   PubMed Web of Science ®Google Scholar
• Conde J, Gomez R, Bianco G, et al. Expanding the adipokine network in cartilage: identification and regulation of novel factors in human and murine chondrocytes. Ann Rheum Dis. 2011 Mar;70(3):551–559.
   PubMed Web of Science ®Google Scholar
• Eisinger K, Bauer S, Schäffler A, et al. Chemerin induces CCL2 and TLR4 in synovial fibroblasts of patients with rheumatoid arthritis and osteoarthritis. Exp Mol Pathol. 2012 Feb;92(1):90–96.
   PubMed Web of Science ®Google Scholar
• Huang K, Du G, Li L, et al. Association of chemerin levels in synovial fluid with the severity of knee osteoarthritis. Biomarkers. 2012 Feb;17(1):16–20.
   PubMed Web of Science ®Google Scholar
• Fernández-Montoya J, Avendaño C, Negredo P. The glutamatergic system in primary somatosensory neurons and its involvement in sensory input-dependent plasticity. Int J Mol Sci. 2017 Dec 27;19(1):69. doi: 10.3390/ijms19010069
   PubMed Web of Science ®Google Scholar
• Castrillon EE, Ernberg M, Cairns BE, et al. Interstitial glutamate concentration is elevated in the masseter muscle of myofascial temporomandibular disorder patients. J Orofac Pain. 2010;24(4):350–360.
   PubMedGoogle Scholar
• Wan M, Ding L, Wang D, et al. Serotonin: a potent immune cell modulator in autoimmune diseases. Front Immunol. 2020 Feb 11;11:186.
   PubMed Web of Science ®Google Scholar
• Dawson A, Ghafouri B, Gerdle B, et al. Effects of experimental tooth clenching on pain and intramuscular release of 5-HT and glutamate in patients with myofascial TMD. Clin J Pain. 2015 Aug;31(8):740–749.
   PubMed Web of Science ®Google Scholar
• Barker PA, Mantyh P, Arendt-Nielsen L, et al. Nerve growth factor signaling and its contribution to pain. J Pain Res. 2020 May 26;13:1223–1241. doi: 10.2147/JPR.S247472
   PubMed Web of Science ®Google Scholar
• Jang MU, Park JW, Kho HS, et al. Plasma and saliva levels of nerve growth factor and neuropeptides in chronic migraine patients. Oral Dis. 2011 Mar;17(2):187–193.
   PubMed Web of Science ®Google Scholar
• Borelli V, Marchioli A, Di Taranto R, et al. Neuropeptides in saliva of subjects with burning mouth syndrome: a pilot study. Oral Dis. 2010 May;16(4):365–374.
   PubMed Web of Science ®Google Scholar
• Fillingim RB, Ohrbach R, Greenspan JD, et al. Psychological factors associated with development of TMD: the OPPERA prospective cohort study. J Pain. 2013 Dec;14(12 Suppl):T75–90.
   PubMed Web of Science ®Google Scholar
• Chen YW, Lin PY, Tu KY, et al. Significantly lower nerve growth factor levels in patients with major depressive disorder than in healthy subjects: a meta-analysis and systematic review. Neuropsychiatr Dis Treat. 2015;11:925–933. doi: 10.2147/NDT.S81432
   PubMed Web of Science ®Google Scholar
• Fischer M, Wille G, Klien S, et al. Brain-derived neurotrophic factor in primary headaches. J Headache Pain. 2012 Aug;13(6):469–475.
   PubMed Web of Science ®Google Scholar
• Jasim H, Ghafouri B, Carlsson A, et al. Daytime changes of salivary biomarkers involved in pain. J Oral Rehabil. 2020 Jul;47(7):843–850.
   PubMed Web of Science ®Google Scholar
• Greco R, Tassorelli C, Sandrini G, et al. Role of calcitonin gene-related peptide and substance P in different models of pain. Cephalalgia. 2008 Feb;28(2):114–126. doi: 10.1111/j.1468-2982.2007.01468.x
   PubMed Web of Science ®Google Scholar
• Burke JG, Watson RWG, McCormack D, et al. Intervertebral discs which cause low back pain secrete high levels of proinflammatory mediators. J Bone Joint Surg Br. 2002 Mar;84(2):196–201. doi: 10.1302/0301-620X.84B2.0840196
   PubMedGoogle Scholar
• Wang H, Moser M, Schiltenwolf M, et al. Circulating cytokine levels compared to pain in patients with fibromyalgia – a prospective longitudinal study over 6 months. J Rheumatol. 2008 Jul;35(7):1366–1370.
   PubMed Web of Science ®Google Scholar
• White AT, Light AR, Hughen RW, et al. Severity of symptom flare after moderate exercise is linked to cytokine activity in chronic fatigue syndrome. Psychophysiology. 2010 Jul 1;47(4):615–624. doi: 10.1111/j.1469-8986.2010.00978.x
   PubMed Web of Science ®Google Scholar
• Slade GD, Conrad MS, Diatchenko L, et al. Cytokine biomarkers and chronic pain: association of genes, transcription, and circulating proteins with temporomandibular disorders and widespread palpation tenderness. Pain. 2011 Dec;152(12):2802–2812.
   PubMed Web of Science ®Google Scholar
• Louca Jounger S, Christidis N, Svensson P, et al. Increased levels of intramuscular cytokines in patients with jaw muscle pain. J Headache Pain. 2017 Dec;18(1):30.
   PubMedGoogle Scholar
• Oh SB, Tran PB, Gillard SE, et al. Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. J Neurosci. 2001 Jul 15;21(14):5027–5035. doi: 10.1523/JNEUROSCI.21-14-05027.2001
   PubMed Web of Science ®Google Scholar
• Kaneyama K, Segami N, Nishimura M, et al. Importance of proinflammatory cytokines in synovial fluid from 121 joints with temporomandibular disorders. Br J Oral Maxillofac Surg. 2002 Oct;40(5):418–423.
   PubMed Web of Science ®Google Scholar
• Almeida LE, Pierce S, Zacharias J, et al. Immunohistochemical analysis of IL-1 beta in the discs of patients with temporomandibular joint dysfunction. Cranio. 2017 Jul;35(4):233–237.
   PubMed Web of Science ®Google Scholar
• Hill-Soderlund AL, Holochwost SJ, Willoughby MT, et al. The developmental course of salivary alpha-amylase and cortisol from 12 to 36 months: relations with early poverty and later behavior problems. Psychoneuroendocrinology. 2015 Feb;52:311–323.
   PubMed Web of Science ®Google Scholar
• Monaco A, Cattaneo R, Mesin L, et al. Dysregulation of the autonomous nervous system in patients with temporomandibular disorder: a pupillometric study. PLoS One. 2012;7(9):e45424. doi: 10.1371/journal.pone.0045424
   PubMed Web of Science ®Google Scholar
• Lin SL, Wu SL, Tsai CC, et al. Serum cortisol level and disc displacement disorders of the temporomandibular joint. J Oral Rehabil. 2016 Jan;43(1):10–15.
   PubMed Web of Science ®Google Scholar
• Monteiro DR, Zuim PRJ, Pesqueira AA, et al. Relationship between anxiety and chronic orofacial pain of temporomandibular disorder in a group of university students. J Prosthodont Res. 2011 Jul;55(3):154–158. doi: 10.1016/j.jpor.2010.11.001
   PubMed Web of Science ®Google Scholar
• Lambert CA, Sanders A, Wilder RS, et al. Chronic HPA axis response to stress in temporomandibular disorder. J Dent Hyg. 2013 Apr;87(2):73–81.
   PubMedGoogle Scholar
• Jiang H, Liu J, Qin X, et al. Gas chromatography‑time of flight/mass spectrometry‑based metabonomics of changes in the urinary metabolic profile in osteoarthritic rats. Exp Ther Med. 2018 Mar;15(3):2777–2785.
   PubMed Web of Science ®Google Scholar
• Armstrong CW, McGregor NR, Lewis DP, et al. The association of fecal microbiota and fecal, blood serum and urine metabolites in myalgic encephalomyelitis/chronic fatigue syndrome. Metabolomics. 2017 Jan;13(1):8.
   Web of Science ®Google Scholar
• Szczesniak O, Hestad KA, Hanssen JF, et al. Isovaleric acid in stool correlates with human depression. Nutr Neurosci. 2016 Aug 8;19(7):279–283. doi: 10.1179/1476830515Y.0000000007
   PubMed Web of Science ®Google Scholar
• Manville RW, Abbott GW. Ancient and modern anticonvulsants act synergistically in a KCNQ potassium channel binding pocket. Nat Commun. 2018 Dec;9(1):3845. doi: 10.1038/s41467-018-06339-2
   PubMedGoogle Scholar
• Chiu DTY. Oxidative stress in biology and medicine. Biomed J. 2014 Jun;37(3):97–98. doi: 10.4103/2319-4170.134087
   PubMedGoogle Scholar
• Gremillion HA. Multidisciplinary diagnosis and management of orofacial pain. Gen Dent. 2002 Apr;50(2):178–86; quiz 187–8.
   Google Scholar
• Vrbanović E, Alajbeg IZ, Vuletić L, et al. Salivary oxidant/antioxidant status in chronic temporomandibular disorders is dependent on source and intensity of pain - a pilot study. Front Physiol. 2018;9:1405. doi: 10.3389/fphys.2018.01405
   PubMed Web of Science ®Google Scholar
• Bertin G, Averbeck D. Cadmium: cellular effects, modifications of biomolecules, modulation of DNA repair and genotoxic consequences (a review). Biochimie. 2006 Nov;88(11):1549–1559. doi: 10.1016/j.biochi.2006.10.001
   PubMed Web of Science ®Google Scholar
• Demir CY, Kocak OF, Bozan N, et al. Is there a role for oxidative stress in temporomandibular joint disorders? J Oral Maxillofac Surg. 2018 Mar;76(3):515–520.
   PubMed Web of Science ®Google Scholar
• Vrbanović E, Lapić I, Rogić D, et al. Changes in salivary oxidative status, salivary cortisol, and clinical symptoms in female patients with temporomandibular disorders during occlusal splint therapy: a 3-month follow up. BMC Oral Health. 2019 Dec;19(1):100. doi: 10.1186/s12903-019-0791-8
   PubMedGoogle Scholar